Zurueck zur Suche

Reporte zur Charge 97NL3

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

3Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
IL 1 MO 1 KY 1

VAERS 1221326

GLAXOSMITHKLINE BIOLOGICALS · TDAP (BOOSTRIX) · Charge 97nl3

mild
Staat
IL
Alter
11,0
Geschlecht
M
Eingang
16.04.2021
Impfdatum
14.04.2021
Beginn
15.04.2021
Tage bis Beginn
1,0
Dosis
5
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Injection site swelling Rash erythematous Skin warm

Symptomtext

Pt reported swelling and redness around the injection site that started 1 day post vaccination. On day 2 (today), patient presented to clinic with an erythematous, indurated area approx 22 cm x 14 cm over the R lateral upper arm extending superiorly to the acromion and inferiorly almost to the elbow. Area was warm but not tender. The area was marked and pt was recommended to apply ice, take diphenhydramine, follow up with PCP in 3-4 days and return to clinic sooner if symptoms worsened (increased area of erythema or swelling, pain, or fever).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
NKDA
Vorherige Impfungen
-

VAERS 1521901

GLAXOSMITHKLINE BIOLOGICALS · TDAP (BOOSTRIX) · Charge 97NL3

gering
Staat
MO
Alter
32,0
Geschlecht
M
Eingang
03.08.2021
Impfdatum
30.06.2021
Beginn
30.06.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

received /on June 30th, 2021/ expired on June 8th, 2021; This case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 32-year-old male patient who received DTPa (Reduced antigen) (Boostrix) (batch number 97NL3, expiry date 8th June 2021) for prophylaxis. Co-suspect products included dtpa vaccine. pre-filled syringe device (Boostrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On 30th June 2021, the patient received Boostrix and Boostrix Pre-Filled Syringe Device. On 30th June 2021, unknown after receiving Boostrix and Boostrix Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The patient received a dose of Boostrix on 30th June 2021, which was expired on 8th June 2021 and led to expired vaccine used. The reporter consented to follow up.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1416406

GLAXOSMITHKLINE BIOLOGICALS · TDAP (BOOSTRIX) · Charge 97NL3

gering
Staat
KY
Alter
11,0
Geschlecht
F
Eingang
22.06.2021
Impfdatum
08.06.2021
Beginn
08.06.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

received an expired dose / (expiration date: June 5th,2021) on June 8th, 2021; This case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 11-year-old female patient who received DTPa (Reduced antigen) (Boostrix) (batch number 97NL3, expiry date 5th June 2021) for prophylaxis. Co-suspect products included dtpa vaccine. pre-filled syringe device (Boostrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On 8th June 2021, the patient received Boostrix and Boostrix Pre-Filled Syringe Device. On 8th June 2021, unknown after receiving Boostrix and Boostrix Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: On 8th June 2021, the patient received Boostrix which was expired on 5th June 2021. Patient initial was not provided. The reporter consented to follow up.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-